TDP-43 post-translational modifications in health and disease

E Buratti - Expert opinion on therapeutic targets, 2018 - Taylor & Francis
Introduction: Nuclear factor TDP-43 is a ubiquitously expressed RNA binding protein that
plays a key causative role in several neurodegenerative diseases, especially in the …

Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis

Y Nitta, A Sugie - Fly, 2022 - Taylor & Francis
The use of Drosophila in neurodegenerative disease research has contributed to the
identification of modifier genes for the pathology. The basis for neurodegenerative disease …

Protein folding alterations in amyotrophic lateral sclerosis

S Parakh, JD Atkin - Brain research, 2016 - Elsevier
Protein misfolding leads to the formation of aggregated proteins and protein inclusions,
which are associated with synaptic loss and neuronal death in neurodegenerative diseases …

Metabolic reprogramming in amyotrophic lateral sclerosis

M Szelechowski, N Amoedo, E Obre, C Léger… - Scientific reports, 2018 - nature.com
Mitochondrial dysfunction in the spinal cord is a hallmark of amyotrophic lateral sclerosis
(ALS), but the neurometabolic alterations during early stages of the disease remain …

Integrated omic analysis delineates pathways modulating toxic TDP-43 protein aggregates in amyotrophic lateral sclerosis

S Rajaratnam, AP Soman, KS Phalguna, SS Pradhan… - Cells, 2023 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a multi-systemic, incurable, amyloid disease affecting
the motor neurons, resulting in the death of patients. The disease is either sporadic or …

Mir-17∼ 92 confers motor neuron subtype differential resistance to ALS-associated degeneration

YT Tung, KC Peng, YC Chen, YP Yen, M Chang… - Cell Stem Cell, 2019 - cell.com
Progressive degeneration of motor neurons (MNs) is the hallmark of amyotrophic lateral
sclerosis (ALS). Limb-innervating lateral motor column MNs (LMC-MNs) seem to be …

MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS

JA Pérez-Cabello, L Silvera-Carrasco… - Proceedings of the …, 2023 - National Acad Sciences
Amyotrophic lateral sclerosis (ALS) is a fatal and incurable neurodegenerative disease
affecting motor neurons and characterized by microglia-mediated neurotoxic inflammation …

Epigenetic mechanisms of gene regulation in amyotrophic lateral sclerosis

A Jimenez-Pacheco, JM Franco, S Lopez… - … in Aging and Disease, 2017 - Springer
Despite being clinically described 150 years ago, the mechanisms underlying amyotrophic
lateral sclerosis (ALS) pathogenesis have not yet been fully understood. Studies in both …

Integrated network pharmacology approach shows a potential role of Ginseng catechins and ginsenosides in modulating protein aggregation in Amyotrophic Lateral …

RS Swaroop, SS Pradhan, VMD Darshan… - 3 Biotech, 2022 - Springer
Amyotrophic lateral Sclerosis is an incurable, progressive neurodegenerative motor neuron
disease. The disease is characterized by protein aggregates. The symptoms include …

Immune signaling kinases in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)

R García-García, L Martín-Herrero… - International Journal of …, 2021 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disorder of
motor neurons in adults, with a median survival of 3–5 years after appearance of symptoms …